Expression of Concern.
- Published in:
- Drug Development Research, 2020, v. 81, n. 5, p. 638, doi. 10.1002/ddr.21718
- Publication type:
- Article
Works matching IS 02724391 AND DT 2020 AND VI 81 AND IP 5
Results: 16
1
2
Corrigendum.
- Published in:
- Drug Development Research, 2020, v. 81, n. 5, p. 637, doi. 10.1002/ddr.21703
- Publication type:
- Article
3
Naphthoquinones, benzoquinones, and anthraquinones: Molecular docking, ADME and inhibition studies on human serum paraoxonase‐1 associated with cardiovascular diseases.
- Published in:
- Drug Development Research, 2020, v. 81, n. 5, p. 628, doi. 10.1002/ddr.21667
- By:
- Publication type:
- Article
4
COVID‐19 treatment by repurposing drugs until the vaccine is in sight.
- Published in:
- Drug Development Research, 2020, v. 81, n. 5, p. 541, doi. 10.1002/ddr.21666
- By:
- Publication type:
- Article
5
D‐ribose‐L‐cysteine enhances memory task, attenuates oxidative stress and acetyl‐cholinesterase activity in scopolamine amnesic mice.
- Published in:
- Drug Development Research, 2020, v. 81, n. 5, p. 620, doi. 10.1002/ddr.21663
- By:
- Publication type:
- Article
6
β‐Glucuronidase‐ and OATP2B1‐mediated drug interaction of scutellarin in Dengzhan Xixin Injection: A formulation aspect.
- Published in:
- Drug Development Research, 2020, v. 81, n. 5, p. 609, doi. 10.1002/ddr.21661
- By:
- Publication type:
- Article
7
Evaluation of the neuropharmacological effects of Gardenin A in mice.
- Published in:
- Drug Development Research, 2020, v. 81, n. 5, p. 600, doi. 10.1002/ddr.21659
- By:
- Publication type:
- Article
8
Nitroglycerin ameliorates liver injury and regulates adaptive immunity in mice.
- Published in:
- Drug Development Research, 2020, v. 81, n. 5, p. 557, doi. 10.1002/ddr.21653
- By:
- Publication type:
- Article
9
Preparation, characterization, and sonodynamic antitumor effect of the folate receptor targeted FA‐EN‐β‐CD containing hematoporphyrin in vitro.
- Published in:
- Drug Development Research, 2020, v. 81, n. 5, p. 585, doi. 10.1002/ddr.21657
- By:
- Publication type:
- Article
10
Angiotensin receptor blockers as tentative SARS‐CoV‐2 therapeutics.
- Published in:
- Drug Development Research, 2020, v. 81, n. 5, p. 537, doi. 10.1002/ddr.21656
- By:
- Publication type:
- Article
11
Synthesis of novel N‐substitutedphenyl‐6‐oxo‐3‐phenylpyridazine derivatives as cyclooxygenase‐2 inhibitors.
- Published in:
- Drug Development Research, 2020, v. 81, n. 5, p. 573, doi. 10.1002/ddr.21655
- By:
- Publication type:
- Article
12
Genetic determinants of circulating VEGF levels in major depressive disorder and electroconvulsive therapy response.
- Published in:
- Drug Development Research, 2020, v. 81, n. 5, p. 593, doi. 10.1002/ddr.21658
- By:
- Publication type:
- Article
13
Effects of different doses of atorvastatin, rosuvastatin, and simvastatin on elderly patients with ST‐elevation acute myocardial infarction (AMI) after percutaneous coronary intervention (PCI).
- Published in:
- Drug Development Research, 2020, v. 81, n. 5, p. 551, doi. 10.1002/ddr.21651
- By:
- Publication type:
- Article
14
Trim14 promotes autophagy and chemotherapy resistance of gastric cancer cells by regulating AMPK/mTOR pathway.
- Published in:
- Drug Development Research, 2020, v. 81, n. 5, p. 544, doi. 10.1002/ddr.21650
- By:
- Publication type:
- Article
15
Issue Information ‐ TOC.
- Published in:
- Drug Development Research, 2020, v. 81, n. 5, p. 535, doi. 10.1002/ddr.21552
- Publication type:
- Article
16
Effect of age and renal impairment on the pharmacokinetics and safety of trimetazidine: An open‐label multiple‐dose study.
- Published in:
- Drug Development Research, 2020, v. 81, n. 5, p. 564, doi. 10.1002/ddr.21654
- By:
- Publication type:
- Article